Home/Health & Medicine/Retraction: atorvastatin may attenuate recurrence of chronic subdural hematoma

Essay, 1 pages (100 words)

Retraction: atorvastatin may attenuate recurrence of chronic subdural hematoma

Subject: Health & Medicine

Info

Published: January 10, 2022
Updated: January 10, 2022
University / College: Durham University
Language: English
Downloads: 38

A retraction of the Original Research Article
Atorvastatin May Attenuate Recurrence of Chronic Subdural Hematoma

by Liu, H., Luo, Z., Liu, Z., Yang, J., and Kan, S. (2016). Front. Neurosci. 10: 303. doi: 10. 3389/fnins. 2016. 00303

The Journal and Authors retract the 28 June 2016 article cited above for the following reasons provided by the Authors:

In one of our collaborating centers (The People’s Hospital of AnQiu City), 38 patients were enrolled in an atorvastatin group. Among them, 26 patients lost to follow-up were categorized and analyzed as “ non-recurrence group.” It was a fundamental error and thus we must retract this article. We apologize for any inconvenience caused by the retraction of this article.

Thank's for Your Vote!

This work, titled "Retraction: atorvastatin may attenuate recurrence of chronic subdural hematoma" was written and willingly shared by a fellow student. This sample can be utilized as a research and reference resource to aid in the writing of your own work. Any use of the work that does not include an appropriate citation is banned.

If you are the owner of this work and don’t want it to be published on AssignBuster, request its removal.

Request Removal

Cite this Essay

References

AssignBuster. (2022) 'Retraction: atorvastatin may attenuate recurrence of chronic subdural hematoma'. 10 January.

Reference

AssignBuster. (2022, January 10). Retraction: atorvastatin may attenuate recurrence of chronic subdural hematoma. Retrieved from https://assignbuster.com/retraction-atorvastatin-may-attenuate-recurrence-of-chronic-subdural-hematoma/

References

AssignBuster. 2022. "Retraction: atorvastatin may attenuate recurrence of chronic subdural hematoma." January 10, 2022. https://assignbuster.com/retraction-atorvastatin-may-attenuate-recurrence-of-chronic-subdural-hematoma/.

1. AssignBuster. "Retraction: atorvastatin may attenuate recurrence of chronic subdural hematoma." January 10, 2022. https://assignbuster.com/retraction-atorvastatin-may-attenuate-recurrence-of-chronic-subdural-hematoma/.

Bibliography

AssignBuster. "Retraction: atorvastatin may attenuate recurrence of chronic subdural hematoma." January 10, 2022. https://assignbuster.com/retraction-atorvastatin-may-attenuate-recurrence-of-chronic-subdural-hematoma/.

Work Cited

"Retraction: atorvastatin may attenuate recurrence of chronic subdural hematoma." AssignBuster, 10 Jan. 2022, assignbuster.com/retraction-atorvastatin-may-attenuate-recurrence-of-chronic-subdural-hematoma/.

Get in Touch

Please, let us know if you have any ideas on improving Retraction: atorvastatin may attenuate recurrence of chronic subdural hematoma, or our service. We will be happy to hear what you think: [email protected]